168 related articles for article (PubMed ID: 20629118)
1. Transient amantadine-induced musical hallucinations in a patient with Parkinson's disease.
Gondim Fde A; Costa HA; Taunay TC; de Oliveira GR; Ferreira JM; Rola FH
Mov Disord; 2010 Jul; 25(10):1505-6. PubMed ID: 20629118
[No Abstract] [Full Text] [Related]
2. An artist's view of drug-induced hallucinosis.
Ebersbach G
Mov Disord; 2003 Jul; 18(7):833-4. PubMed ID: 12815666
[TBL] [Abstract][Full Text] [Related]
3. [Tactile hallucinations induced by trihexyphenidyl in a patient with Parkinson's disease].
Funakawa I; Jinnai K
Rinsho Shinkeigaku; 2005 Feb; 45(2):125-7. PubMed ID: 15782612
[TBL] [Abstract][Full Text] [Related]
4. Dropped head associated with amantadine in Parkinson disease.
Kataoka H; Ueno S
Clin Neuropharmacol; 2011; 34(1):48-9. PubMed ID: 21242745
[TBL] [Abstract][Full Text] [Related]
5. Plasma amantadine concentrations in patients with Parkinson's disease.
Nishikawa N; Nagai M; Moritoyo T; Yabe H; Nomoto M
Parkinsonism Relat Disord; 2009 Jun; 15(5):351-3. PubMed ID: 18823813
[TBL] [Abstract][Full Text] [Related]
6. Amantadine induced reversible corneal edema.
Deogaonkar M; Wilson K; Vitek J
J Clin Neurosci; 2011 Feb; 18(2):298-9. PubMed ID: 21163653
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced delusions of parasitosis during treatment of Parkinson's disease.
Swick BL; Walling HW
J Am Acad Dermatol; 2005 Dec; 53(6):1086-7. PubMed ID: 16310077
[No Abstract] [Full Text] [Related]
8. Amantadine-induced livedo reticularis: a report of two cases.
Hayes BB; Cook-Norris RH; Miller JL; Rodriguez A; Zic JA
J Drugs Dermatol; 2006 Mar; 5(3):288-9. PubMed ID: 16573266
[TBL] [Abstract][Full Text] [Related]
9. Renaissance of amantadine in the treatment of Parkinson's disease.
Blanchet PJ; Metman LV; Chase TN
Adv Neurol; 2003; 91():251-7. PubMed ID: 12442683
[No Abstract] [Full Text] [Related]
10. [Hallucinatory symptoms in Parkinson's disease during treatment with anti-parkinsonian drugs].
Nagano O; Takauchi S; Nishitani H; Miyoshi K
Rinsho Shinkeigaku; 1986 May; 26(5):464-70. PubMed ID: 3742899
[No Abstract] [Full Text] [Related]
11. Multiple impulse control disorders developing in Parkinson's disease after initiation of amantadine.
Walsh RA; Lang AE
Mov Disord; 2012 Feb; 27(2):326. PubMed ID: 21954056
[No Abstract] [Full Text] [Related]
12. Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine: report of a case series.
Singer C; Papapetropoulos S; Gonzalez MA; Roberts EL; Lieberman A
Mov Disord; 2005 Jul; 20(7):873-7. PubMed ID: 15809995
[TBL] [Abstract][Full Text] [Related]
13. Delusional infestation induced by piribedil add-on in Parkinson's disease.
Kölle M; Lepping P; Kassubek J; Schönfeldt-Lecuona C; Freudenmann RW
Pharmacopsychiatry; 2010 Aug; 43(6):240-2. PubMed ID: 20614418
[No Abstract] [Full Text] [Related]
14. Sudden bilateral corneal oedema in a patient with Parkinson's disease.
Park CY; Chuck RS
Acta Ophthalmol; 2011 Mar; 89(2):198-9. PubMed ID: 19604157
[No Abstract] [Full Text] [Related]
15. Amantadine and other antiglutamate agents: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S13-22. PubMed ID: 12211136
[No Abstract] [Full Text] [Related]
16. [Hallucinations in Parkinson's disease].
Moser A; Hagenah J; Kömpf D
Nervenarzt; 2003 Apr; 74(4):376-85, quiz 385-6. PubMed ID: 12707709
[TBL] [Abstract][Full Text] [Related]
17. Administration of selegiline is not associated with visual hallucinations in advanced Parkinson's disease patients.
Papapetropoulos S; Argyriou AA
Parkinsonism Relat Disord; 2005 Jun; 11(4):265-6; author reply 267. PubMed ID: 15878591
[No Abstract] [Full Text] [Related]
18. Trial of amantadine in Parkinson's disease.
Campbell AM; Williams MJ
Br J Clin Pract; 1972 Jan; 26(1):19-22. PubMed ID: 4554563
[No Abstract] [Full Text] [Related]
19. Features associated with the development of hallucinations in Parkinson's disease.
Benbir G; Ozekmekçi S; Cinar M; Beskardes F; Apaydin H; Erginöz E
Acta Neurol Scand; 2006 Oct; 114(4):239-43. PubMed ID: 16942542
[TBL] [Abstract][Full Text] [Related]
20. Hallucinations in Parkinson's disease: the clinical syndrome.
Goetz CG
Adv Neurol; 1999; 80():419-23. PubMed ID: 10410750
[No Abstract] [Full Text] [Related]
[Next] [New Search]
